Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.45B |
| 2 |
Visa
V
|
+$1.05B |
| 3 |
Microsoft
MSFT
|
+$1.01B |
| 4 |
Apple
AAPL
|
+$578M |
| 5 |
Norfolk Southern
NSC
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.24B |
| 2 |
McDonald's
MCD
|
+$707M |
| 3 |
JPMorgan Chase
JPM
|
+$680M |
| 4 |
Texas Instruments
TXN
|
+$678M |
| 5 |
Edwards Lifesciences
EW
|
+$664M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.8% |
| 2 | Healthcare | 2.66% |
| 3 | Financials | 2.38% |
| 4 | Consumer Discretionary | 2.05% |
| 5 | Industrials | 2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11601
Globus Maritime Ltd
GLBS
$68.4M
| $130K | ﹤0.01% |
121,747
-62,443
| -34% | -$67.6K |
|
11602
eGain
EGAN
$202M
| $130K | ﹤0.01% |
+14,939
| New | +$104K |
|
11603
Cumberland Pharmaceuticals
CPIX
$115M
| $129K | ﹤0.01% |
41,445
-32,961
| -44% | -$110K |
|
11604
PUT
Vanda Pharmaceuticals
VNDA
$308M
| $129K | ﹤0.01% |
25,900
-29,200
| -53% | -$135K |
|
11605
CALL
Goldman Sachs BDC
GSBD
$1.02B
| $129K | ﹤0.01% |
+12,700
| New | +$144K |
|
|
TEF
11606
CALL
DELISTED
Telefonica
TEF
| $129K | ﹤0.01% |
25,400
+6,000
| +31% | +$31.9K |
|
11607
CALL
Marten Transport
MRTN
$1.21B
| $129K | ﹤0.01% |
12,100
-182,500
| -94% | -$2.22M |
|
11608
PUT
AMC Global Media
AMCX
$490M
| $129K | ﹤0.01% |
15,600
-4,200
| -21% | -$29.1K |
|
11609
CALL
Coherus Oncology
CHRS
$194M
| $128K | ﹤0.01% |
78,300
+52,600
| +205% | +$58.5K |
|
|
LYRA
11610
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $128K | ﹤0.01% |
+19,484
| New | +$143K |
|
11611
PUT
Greystone Housing Impact Investors LP
GHI
$136M
| $128K | ﹤0.01% |
12,400
-2,000
| -14% | -$21.8K |
|
|
VWAV
11612
PUT
VisionWave Holdings
VWAV
$34.2M
| $128K | ﹤0.01% |
+13,400
| New | +$108K |
|
11613
PUT
Humacyte
HUMA
$191M
| $128K | ﹤0.01% |
73,300
-25,500
| -26% | -$50K |
|
|
GCV
11614
Gabelli Convertible and Income Securities Fund
GCV
$93.3M
| $127K | ﹤0.01% |
30,828
+9,506
| +45% | +$38K |
|
11615
PUT
Franklin Wireless
FKWL
$26.8M
| $127K | ﹤0.01% |
29,200
-23,700
| -45% | -$96K |
|
11616
PUT
Olema Pharmaceuticals
OLMA
$1.03B
| $127K | ﹤0.01% |
13,000
-18,400
| -59% | -$110K |
|
|
BORR
11617
CALL
Borr Drilling
BORR
$1.2B
| $127K | ﹤0.01% |
47,300
+17,600
| +59% | +$43.8K |
|
|
MTA
11618
PUT
Metalla Royalty & Streaming
MTA
$785M
| $127K | ﹤0.01% |
20,000
-30,800
| -61% | -$146K |
|
|
BCIC
11619
BCP Investment Corp
BCIC
$91.5M
| $127K | ﹤0.01% |
11,004
-38,807
| -78% | -$478K |
|
|
ADAM
11620
CALL
Adamas Trust
ADAM
$856M
| $127K | ﹤0.01% |
+18,200
| New | +$127K |
|
|
LOMA
11621
PUT
Loma Negra
LOMA
$1.26B
| $127K | ﹤0.01% |
17,200
-6,300
| -27% | -$62.7K |
|
11622
CALL
Virco
VIRC
$95.2M
| $126K | ﹤0.01% |
+16,300
| New | +$133K |
|
|
NUTR
11623
Nusatrip Inc
NUTR
| $126K | ﹤0.01% |
+15,803
| New | +$83.3K |
|
11624
AlTi Global
ALTI
$481M
| $126K | ﹤0.01% |
+35,394
| New | +$147K |
|
11625
IRIDEX
IRIX
$14.6M
| $126K | ﹤0.01% |
109,473
+78,302
| +251% | +$96.3K |
|
Similar funds
Citadel Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Citadel Advisors held 14,587 positions worth $657B, up 14% from $576B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citadel Advisors's Q3 2025 filing shows 2,292 new, 5,365 increased, 4,887 reduced and 1,963 closed positions. Its largest new stake was Permian Resources: 18,381,735 shares worth $235M. The largest sale was Hess, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3.3% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q3 2025 buy was Permian Resources: 18,381,735 shares worth $235M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q3 2025, an estimated $1.45B increase.
- Citadel Advisors's biggest Q3 2025 reduction was McDonald's, cutting an estimated $707M.
- Citadel Advisors fully exited Hess in Q3 2025, selling an estimated $1.24B.
- Citadel Advisors's ten largest holdings make up 25% of its $657B portfolio in Q3 2025.
- Citadel Advisors opened 2,292 new positions and closed 1,963 in Q3 2025.
- Citadel Advisors's portfolio value rose 14% quarter-over-quarter to $657B.
Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.